Sort
46,585 grants matching “heart failure”
Protein carbamylation and uremic cardiomyopathy in chronic kidney disease
$437,500Anders Hayden Berg · Beth Israel Deaconess Medical Center · R01 · FY2018 · HL
Development of Novel Approaches for the Pharmacologic Treatment of Atrial Fibrill
$437,500Charles Antzelevitch · Masonic Medical Research Laboratory, Inc · R01 · FY2011 · HL
Neuropeptides reduce thrombosis risk in heart failure
$437,500Wohaib Hasan · Cedars-Sinai Medical Center · R01 · FY2020 · HL
Endoglin: A New Target of Therapy for Heart Failure
$437,500Navin Kumar Kapur · Tufts Medical Center · R01 · FY2016 · HL
Characterizing the Role of CMV Latency in Solid Organ Transplant Rejection
$437,500Daniel N Streblow · Oregon Health & Science University · R56 · FY2015 · AI
Altered Cell-Cell Coupling in Arrhythmogenic Cardiomyopathy
$437,500Jeffrey E Saffitz · Beth Israel Deaconess Medical Center · R01 · FY2020 · HL
Neuropeptides reduce thrombosis risk in heart failure
$437,500Wohaib Hasan · Cedars-Sinai Medical Center · R01 · FY2018 · HL
Altered Cell-Cell Coupling in Arrhythmogenic Cardiomyopathy
$437,500Jeffrey E Saffitz · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL
Prevention of Vascular Calcification In Chronic Kidney Disease
$437,500W Charles O'Neill · Emory University · R01 · FY2017 · HL
Development of Novel Approaches for the Pharmacologic Treatment of Atrial Fibrill
$437,500Charles Antzelevitch · Masonic Medical Research Laboratory, Inc · R01 · FY2012 · HL
Epigenetic Mechanisms of Myocardial Regeneration
$437,500Yiqiang Zhang · University Of Washington · R56 · FY2016 · HL
Characterizing the Role of CMV Latency in Solid Organ Transplant Rejection
$437,500Daniel N Streblow · Oregon Health & Science University · R01 · FY2017 · AI
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains
$437,500Tingting Hong · Cedars-Sinai Medical Center · R01 · FY2018 · HL
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains
$437,500Tingting Hong · Cedars-Sinai Medical Center · R01 · FY2016 · HL
Neuropeptides reduce thrombosis risk in heart failure
$437,500Wohaib Hasan · Cedars-Sinai Medical Center · R01 · FY2019 · HL
DYNAMIC CARDIOMYOPLASTY
$437,493Temple University · R01 · FY2001 · HL
Novel Stabilization Catheter for His Pacing Lead Implant
$437,461William Combs · 3dt Holdings, Llc · R43 · FY2024 · HL
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension
$437,404Zhiyu Dai · Washington University · R01 · FY2025 · HL
NEK7 suppresses inflammation in the aging heart through regulation of RNA binding proteins
$437,375Shigeki Miyamoto · University Of California, San Diego · R21 · FY2025 · AG
Training in Cardiovascular Physiology and Pharmacology
$437,370Kirk U Knowlton · University Of California, San Diego · T32 · FY2009 · HL
The role of amphiregulin in mediating radiation cystitis in cancer survivors
$437,368Bernadette Margaretha Maria Zwaans · William Beaumont Hospital Research Inst · R01 · FY2024 · DK
Functional Assessment of the Locus for Atrial Fibrillation on Chromosome 4q25
$437,313Patrick Thomas Ellinor · Massachusetts General Hospital · R21 · FY2010 · DA
Treatment of Pulmonary Edema in Organ Donors
$437,279Lorraine B Ware · Vanderbilt University · R01 · FY2011 · HL
Serial evaluation of cardioprotective effects of exercise training in heart failure using cardiac diffusion tensor MRI
$437,266Christopher T Nguyen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · HL
Cardiac microlesion formation during invasive pneumococcal disease
$437,199Carlos J Orihuela · University Of Alabama At Birmingham · R01 · FY2022 · AI